Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Syndrome Following Transplant for Leukemia

NCT00920842 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT00920842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00920842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Syndrome Following Transplant for Leukemia
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Observational
Overall status
Completed
Start date
April 30, 2005
Completion date
November 30, 2012
Enrollment
244 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular complications, leukemia, long-term effects secondary to cancer therapy in children, metabolic syndrome